Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling
- PMID: 22522909
- PMCID: PMC3398985
- DOI: 10.4161/epi.20219
Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling
Abstract
Epigenetic alterations are a common event in lung cancer and their identification can serve to inform on the carcinogenic process and provide clinically relevant biomarkers. Using paired tumor and non-tumor lung tissues from 146 individuals from three independent populations we sought to identify common changes in DNA methylation associated with the development of non-small cell lung cancer. Pathologically normal lung tissue taken at the time of cancer resection was matched to tumorous lung tissue and together were probed for methylation using Illumina GoldenGate arrays in the discovery set (n = 47 pairs) followed by bisulfite pyrosequencing for validation sets (n = 99 pairs). For each matched pair the change in methylation at each CpG was calculated (the odds ratio), and these ratios were averaged across individuals and ranked by magnitude to identify the CpGs with the greatest change in methylation associated with tumor development. We identified the top gene-loci representing an increase in methylation (HOXA9, 10.3-fold and SOX1, 5.9-fold) and decrease in methylation (DDR1, 8.1-fold). In replication testing sets, methylation was higher in tumors for HOXA9 (p < 2.2 × 10 (-16) ) and SOX1 (p < 2.2 × 10 (-16) ) and lower for DDR1 (p < 2.2 × 10 (-16) ). The magnitude and strength of these changes were consistent across squamous cell and adenocarcinoma tumors. Our data indicate that the identified genes consistently have altered methylation in lung tumors. Our identified genes should be included in translational studies that aim to develop screening for early disease detection.
Figures

Similar articles
-
Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.Cancer Lett. 2011 Dec 1;311(1):29-37. doi: 10.1016/j.canlet.2011.06.021. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21757291
-
Genome-wide CpG island methylation analyses in non-small cell lung cancer patients.Carcinogenesis. 2013 Mar;34(3):513-21. doi: 10.1093/carcin/bgs363. Epub 2012 Nov 19. Carcinogenesis. 2013. PMID: 23172663
-
Methylation markers of early-stage non-small cell lung cancer.PLoS One. 2012;7(6):e39813. doi: 10.1371/journal.pone.0039813. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768131 Free PMC article.
-
Lung cancer: from single-gene methylation to methylome profiling.Cancer Metastasis Rev. 2010 Mar;29(1):95-107. doi: 10.1007/s10555-010-9203-x. Cancer Metastasis Rev. 2010. PMID: 20099008 Review.
-
Genomics of squamous cell lung cancer.Oncologist. 2013 Jun;18(6):707-16. doi: 10.1634/theoncologist.2013-0063. Epub 2013 May 31. Oncologist. 2013. PMID: 23728941 Free PMC article. Review.
Cited by
-
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses.JCO Precis Oncol. 2021 Feb 19;5:PO.20.00151. doi: 10.1200/PO.20.00151. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036228 Free PMC article.
-
Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.Clin Cancer Res. 2014 Apr 1;20(7):1856-64. doi: 10.1158/1078-0432.CCR-13-2109. Epub 2014 Jan 31. Clin Cancer Res. 2014. PMID: 24486589 Free PMC article.
-
The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development.Cancers (Basel). 2021 Apr 6;13(7):1725. doi: 10.3390/cancers13071725. Cancers (Basel). 2021. PMID: 33917302 Free PMC article. Review.
-
Upregulation of HOXA11 during the progression of lung adenocarcinoma detected via multiple approaches.Int J Mol Med. 2018 Nov;42(5):2650-2664. doi: 10.3892/ijmm.2018.3826. Epub 2018 Aug 14. Int J Mol Med. 2018. PMID: 30106131 Free PMC article.
-
Epigenetic influences in the aetiology of cancers arising from breast and prostate: a hypothesised transgenerational evolution in chromatin accessibility.ISRN Oncol. 2013;2013:624794. doi: 10.1155/2013/624794. Epub 2013 Feb 3. ISRN Oncol. 2013. PMID: 23431470 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society; 2012.
-
- Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–28. - PubMed
-
- Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, et al. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res. 2001;61:3419–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 ES006717/ES/NIEHS NIH HHS/United States
- P30 CA077598/CA/NCI NIH HHS/United States
- P42 ES007373/ES/NIEHS NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- R01CA100679/CA/NCI NIH HHS/United States
- R01CA121147/CA/NCI NIH HHS/United States
- P42 ES005947/ES/NIEHS NIH HHS/United States
- R01CA126939/CA/NCI NIH HHS/United States
- R01 CA126939/CA/NCI NIH HHS/United States
- R01CA57494/CA/NCI NIH HHS/United States
- P30CA077598/CA/NCI NIH HHS/United States
- P20 RR018728/RR/NCRR NIH HHS/United States
- R01 CA057494/CA/NCI NIH HHS/United States
- R01CA126831/CA/NCI NIH HHS/United States
- R01 CA126831/CA/NCI NIH HHS/United States
- R01 CA078609/CA/NCI NIH HHS/United States
- R01 CA121147/CA/NCI NIH HHS/United States
- R01CA078609/CA/NCI NIH HHS/United States
- P42ES007373/ES/NIEHS NIH HHS/United States
- R01 CA100679/CA/NCI NIH HHS/United States
- R01CA52689/CA/NCI NIH HHS/United States
- R01 CA052689/CA/NCI NIH HHS/United States
- R01ES006717/ES/NIEHS NIH HHS/United States
- P20RR018728/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases